HT Supreme® Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
SinoMed_admin2023-07-24T14:40:52+08:002021-10-27
About SinoMed_admin
This author has not yet filled in any details.So far SinoMed_admin has created 48 blog entries.
SinoMed_admin
SINOMED announces the first commercial implantation and European launch of the HT Supreme Drug Eluting Stent
SinoMed_admin2021-09-26T16:31:29+08:002021-8-17
SINOMED announces a clinical collaboration with the National University of Ireland Galway to evaluate a non-invasive assessment method for stenting
SinoMed_admin2021-07-07T14:26:20+08:002021-7-5
SINOMED announces the HT Supreme DES has similar performance as the market-leader across the spectrum of lesion complexity
SinoMed_admin2021-07-07T13:49:39+08:002021-5-27
Late-Breaking Study Results of the HT Supreme™ Healing-Targeted DES Demonstrated Equivalent Outcomes with Exceptional Safety
SinoMed_admin2021-05-17T17:44:56+08:002020-11-17
SINOMED Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme Coronary Drug-Eluting Stent
SinoMed_admin2021-05-17T17:45:38+08:002020-7-13
SINOMED was listed on the STAR Market of the Shanghai Stock Exchange
SinoMed_admin2020-11-13T10:45:47+08:002019-10-30